Sonoma Pharmaceuticals, Inc.
SNOA
$2.97
$0.051.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.27% | -7.16% | 58.89% | 19.39% | 18.43% |
| Total Depreciation and Amortization | -24.39% | -26.67% | -22.22% | -13.33% | 20.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,458.62% | -106.82% | -76.19% | -17.92% | -93.95% |
| Change in Net Operating Assets | -82.77% | 495.15% | 777.67% | -111.33% | 169.81% |
| Cash from Operations | -162.50% | 151.18% | 128.76% | -324.19% | 106.23% |
| Capital Expenditure | -361.11% | -100.00% | -1,200.00% | 70.59% | 109.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -361.11% | -100.00% | -1,200.00% | 70.59% | 121.95% |
| Total Debt Issued | -26.54% | -- | -- | -- | -27.57% |
| Total Debt Repaid | 13.83% | 35.94% | 5.43% | 8.46% | 6.00% |
| Issuance of Common Stock | -85.71% | -45.18% | -- | -- | -88.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -61.09% | -46.28% | 1,219.38% | 571.11% | -81.55% |
| Foreign Exchange rate Adjustments | 154.29% | -301.79% | -528.89% | -383.52% | -120.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -80.89% | 330.48% | 205.83% | -95.29% | -39.12% |